Breaking News

ICIG Acquires Sandoz Site in Frankfurt-Höchst

Sandoz Industrial Products will maintain its operations associated with the CordenPharma Group, the pharma platform of ICIG

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

International Chemical Investors Group (ICIG) and Novartis Group have entered into an agreement under which ICIG will acquire all of the shares in Sandoz Industrial Products GmbH, a Frankfurt-Höchst-based manufacturer of enzyme-based fermentation products and intermediates for the pharmaceutical industry, especially for the use in antibiotics. Closing of the transaction is anticipated to occur on April 1, 2016. Sandoz’s decision to withdraw from the production of intermediates for 7-ACA antib...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters